Europe $20B in the hole to Big Pharma
A new report released by the European Federation of Pharmaceutical Industries and Associations (EFPIA) claims that certain financially troubled countries in Europe have outstanding invoices to the pharmaceutical industry approaching $20 billion. According to EFPIA president and GSK CEO Andrew Witty, the unpaid bills represent roughly 8% of the drug industry’s sales in the continent. [...]
No comments:
Post a Comment